Evolv Technology Completes Restatement of Previously Issued Financial Statements and Reports Third Quarter, Fourth Quarter and Full Year 2024 Financial Results
— Company Regains Compliance with SEC Reporting and NASDAQ Listing Requirements — — Company Achieves Positive Adjusted EBITDA1 in Q4’24 — Q4’24... Read more.
Calix Announces Upcoming Investor Events
SAN JOSE, Calif.–(BUSINESS WIRE)–Calix, Inc. (NYSE: CALX) today announced that Calix management will participate in the upcoming investor events: Event:... Read more.
NRC Health Announces First Quarter Results
LINCOLN, Neb.–(BUSINESS WIRE)–National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the first quarter 2025 and other... Read more.
Personalis’ NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study
100% of resectable Stage I-IV colorectal cancer relapses were detected ahead of imaging, with 87% of those relapses having been detected in the first eight weeks... Read more.
IFF Pharma Solutions to Showcase Portfolio at Excipient World 2025
Sustainability Expert Will Share Key Insights on Industry-Leading Solutions for Improving Environmental Impact NEW YORK–(BUSINESS WIRE)–IFF (NYSE: IFF)... Read more.
Neurogene Announces Upcoming Oral Presentation on Monitoring and Treatment to Reverse Rare Complication of High Dose Gene Therapy at the ASGCT Annual Meeting
Presentation will highlight examples of successful surveillance and treatment of HLH in the context of gene therapy NEW YORK–(BUSINESS WIRE)–Neurogene... Read more.
Chain Bridge Bancorp, Inc. Reports First Quarter 2025 Financial Results
MCLEAN, Va.–(BUSINESS WIRE)–Chain Bridge Bancorp, Inc. (NYSE: CBNA) (the “Company”), the holding company for Chain Bridge Bank, N.A. (the “Bank”),... Read more.
Atomera Announces Agreement with Leading Capital Equipment Company to Bring Innovative Materials to Market
Cooperative development activities aim to fast-track adoption of MST® for advanced node customers LOS GATOS, Calif.–(BUSINESS WIRE)–Atomera Incorporated... Read more.
Be Biopharma to Present at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
Oral presentation to feature nonclinical data for BE-102 for the potential treatment of hypophosphatasia Poster to highlight potential of BCMs as an allogenic off-the-shelf... Read more.
Potential First-in-Class Data from Preclinical Program for STX-003, a Programmable mRNA Therapy to Treat Solid Tumor Cancers
Proof-of-concept shows mRNA genetic circuitry able to target expression of IL-12 to tumors when systemically delivered Company to share updates at the AACR and ASGCT... Read more.